Determination of sodium valproate in blood by capillary isotachophoresisPOLONSKI, J; BUZINKAIOWA, T; GAZALOWA, E et al.Journal of analytical chemistry (New York, NY). 1993, Vol 48, Num 3, pp 409-411, issn 1061-9348, 2Article

Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adultsMEADOR, K. J; LORING, D. W; MOORE, E. E et al.Neurology. 1995, Vol 45, Num 8, pp 1494-1499, issn 0028-3878Article

Etude comparative du valproate de sodium et du kétoprofène dans le traitement de la douleur postopératoire = Comparative study of sodium valproate and ketoprofen in postoperatoire painMARTIN, C; MARTIN, A; RUD, C et al.Annales françaises d'anesthésie et de réanimation. 1987, Vol 7, Num 5, pp 387-392, issn 0750-7658Article

Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbitalBRIZENDINE, Christina E; NAIK, Paras J.American journal of health-system pharmacy. 2013, Vol 70, Num 6, pp 507-510, issn 1079-2082, 4 p.Article

Relation of serum valproate concentration to response in maniaBOWDEN, C. L; JANICAK, P. G; RISCH, S. C et al.The American journal of psychiatry. 1996, Vol 153, Num 6, pp 765-770, issn 0002-953XArticle

Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration, and diagnosisAMAN, M. G; WERRY, J. S; PAXTON, J. W et al.Epilepsia (Copenhagen). 1987, Vol 28, Num 2, pp 115-124, issn 0013-9580Article

A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute maniaBOWDEN, Charles L; SWANN, Alan C; CALABRESE, Joseph R et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 10, pp 1501-1510, issn 0160-6689, 10 p.Article

Direct observation of 3-keto-valproate in urine by 2D-NMR spectroscopyMESHITSUKA, Shunsuke; KOEDA, Tatsuya; MURO, Hideki et al.Clinica chimica acta. 2003, Vol 334, Num 1-2, pp 145-151, issn 0009-8981, 7 p.Article

Acidose et hyperlactatémie lors des intoxications aiguës par le valproate de sodium = Acidosis and hyperlactatemia in acute sodium valproate intoxicationDUMOULIN, A; LAPOSTOLLE, F; ADNET, F et al.La Presse médicale (1983). 1997, Vol 26, Num 12, pp 555-557, issn 0755-4982Article

Optimizing treatment in forms of bipolar disorder. SymposiumThe Journal of clinical psychiatry. 1995, Vol 56, issn 0160-6689, 37 p., SUP3Conference Proceedings

Harnsäureserumkonzentration und antiepileptische Therapie im Kindesalter = Uric acid serum concentration and antiepileptic treatment in childhoodFICHSEL, G; FICHSEL, H; LIAPPIS, N et al.Klinische Pädiatrie. 1993, Vol 205, Num 6, pp 429-431, issn 0300-8630Article

haematological disturbances during long-term valproate therapyBRICHARD, B; VERMYLEN, C; SCHEIFF, J. M et al.European journal of pediatrics. 1994, Vol 153, Num 5, pp 378-380, issn 0340-6199Article

Plasma-Prolaktin-Erniedrigung unter Valproattherapie Ausdruck einer Aktivitätssteigerung des zentralen GABA ergen Systems = Diminution du taux de prolactine sérique au cours du traitement par le valproate. Signe d'une augmentation de l'activité GABA ergique centrale = Decrease of plasma prolactin level during Valproat therapy. A sign of increase activity of the central GABergic systemKURLEMANN, G; PALM, D. G.Monatsschrift für Kinderheilkunde. 1987, Vol 135, Num 4, pp 218-219, issn 0026-9298Article

The medical treatment of the hypersecreting pituitary glandCORENBLUM, B.Canadian journal of neurological sciences. 1985, Vol 12, Num 3, pp 243-250, issn 0317-1671Article

Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderlyPORSTEINSSON, Anton P.Drugs & aging. 2006, Vol 23, Num 11, pp 877-886, issn 1170-229X, 10 p.Article

Prevention of postpartum episodes in women with bipolar disorderWISNER, Katherine L; HANUSA, Barbara H; PEINDL, Kathleen S et al.Biological psychiatry (1969). 2004, Vol 56, Num 8, pp 592-596, issn 0006-3223, 5 p.Article

Cheveux crépus acquis induits par le valproate de sodium = Sodium valproate-induced kinky hair syndromeCANEPPELE, S; MAZEREEUW-HAUTIER, J; BONAFE, J.-L et al.Annales de dermatologie et de vénéréologie. 2001, Vol 128, Num 2, pp 134-135, issn 0151-9638Article

Divalproex sodium for impulsive aggressive behavior in patients with personality disorderKAVOUSSI, R. J; COCCARO, E. F.The Journal of clinical psychiatry. 1998, Vol 59, Num 12, pp 676-680, issn 0160-6689Article

Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer DiseaseTARIOT, Pierre N; SCHNEIDER, Lon S; PORSTEINSSON, Anton et al.Archives of general psychiatry. 2011, Vol 68, Num 8, pp 853-861, issn 0003-990X, 9 p.Article

Divalproex extended-release in acute bipolar II depressionWANG, P. W; NOWAKOWSKA, C; CHANDLER, R. A et al.Journal of affective disorders. 2010, Vol 124, Num 1-2, pp 170-173, issn 0165-0327, 4 p.Article

Extended-release divalproex in child and adolescent outpatients with epilepsyKERNITSKY, Lydia; O'HARA, Kathryn A; PING JIANG et al.Epilepsia (Copenhagen). 2005, Vol 46, Num 3, pp 440-443, issn 0013-9580, 4 p.Article

Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placeboBOWDEN, Charles L; COLLINS, Michelle A; MCELROY, Susan L et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 10, pp 1932-1939, issn 0893-133X, 8 p.Article

CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithiumGRIMES, Carol A; JOPE, Richard S.Journal of neurochemistry. 2001, Vol 78, Num 6, pp 1219-1232, issn 0022-3042Article

Treatment of charles Bonnet syndrome with valproateHORI, H; TERAO, T; SHIRAISHI, Y et al.International clinical psychopharmacology. 2000, Vol 15, Num 2, pp 117-119, issn 0268-1315Article

Page / 16